Primary Biliary Cirrhosis: Clinical Trials

11 trials for Primary Biliary Cirrhosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 unknown, 2 withdrawn. 11 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 111Completed 6, Unknown 3, Withdrawn 2
Phase 25Completed 2, Unknown 2, Withdrawn 1

Follow Primary Biliary Cirrhosis: new trials by email Literature Review of Primary Biliary Cirrhosis trials Research Report on Primary Biliary Cirrhosis

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia
Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation - Primary Biliary Cirrhosis
Phase 1 / Phase 2CompletedVinmec Research Institute of Stem Cell and Gene Technology202019-08-102024-06-06
An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects
3 mg [14C]-A4250 capsule - Orphan Cholestatic Liver Diseases, Progressive Familial Intrahepatic Cholestasis
Phase 1CompletedAlbireo62017-01-312024-03-07
Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA
Fenofibrate, UDCA - Primary Biliary Cirrhosis
Phase 1 / Phase 2WithdrawnBeijing 302 Hospital2016-01-012021-09-17
Pilot Study of FFP104 Dose Escalation in PBC Subjects
FFP104 - Primary Biliary Cirrhosis
Phase 1 / Phase 2UnknownFast Forward Pharmaceuticals242015-05-012016-08-24
A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384
A4250, CRC (A3384), Questran - Orphan Cholestatic Liver Diseases, Primary Biliary Cirrhosis
Phase 1CompletedAlbireo942013-07-012024-03-07
Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT
11C-CSar, ICG - Cholestasis, Primary Sclerosing Cholangitis
Phase 1CompletedUniversity of Aarhus222013-06-012015-02-23
Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis
Biological: mesenchymal stem cell, ursodeoxycholic acid - Primary Biliary Cirrhosis
Phase 1UnknownRobert Chunhua Zhao, MD, PhD202011-11-012012-08-03
Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis
conventional plus UC-MSC treatment, Conventional plus placebo treatment - Primary Biliary Cirrhosis
Phase 1 / Phase 2UnknownBeijing 302 Hospital1002011-10-012013-05-31
Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC)
Modafinil - Fatigue, Primary Biliary Cirrhosis
Phase 1CompletedMayo Clinic402009-06-012012-01-18
Initial Study of Rituximab to Treat Primary Biliary Cirrhosis
rituximab - Primary Biliary Cirrhosis
Phase 1 / Phase 2CompletedUniversity of California, Davis62007-01-012017-07-02
Stem Cell Transplantation in Patients With Primary Biliary Cirrhosis
Non-myeloablative Hematopoietic Stem Cell Transplantation - Primary Biliary Cirrhosis
Phase 1WithdrawnRichard Burt, MD2006-01-012012-10-08

Narrower conditions

Liver Cirrhosis, Biliary (11)  ·  Alagille Syndrome (2)  ·  Cholestasis, progressive familial intrahepatic 1 (2)  ·  Biliary Atresia (1)  ·  Cholangitis, Sclerosing (1)  ·  Cholestasis (1)  ·  Fatigue (1)  ·  Inflammation (1)  ·  Liver Cirrhosis (1)

Broader conditions

Bile Duct Diseases (11)  ·  Biliary Tract Diseases (11)  ·  Cholestasis, Intrahepatic (11)  ·  Digestive System Diseases (11)  ·  Fibrosis (11)  ·  Liver Diseases (11)  ·  Pathologic Processes (11)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Cholestasis (10)  ·  Liver Cirrhosis (10)  ·  Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Abnormalities, Multiple (2)  ·  Cardiovascular Abnormalities (2)  ·  Cardiovascular Diseases (2)

Interventions

Ursodeoxycholic Acid (2)  ·  Cholestyramine Resin (1)  ·  Congresses as Topic (1)  ·  Fenofibrate (1)  ·  Indocyanine Green (1)  ·  Modafinil (1)  ·  Rituximab (1)  ·  Transplantation (1)  ·  cholylsarcosine (1)

Sponsors

Albireo (2)  ·  Beijing 302 Hospital (2)  ·  Fast Forward Pharmaceuticals (1)  ·  Mayo Clinic (1)  ·  Richard Burt, MD (1)  ·  Robert Chunhua Zhao, MD, PhD (1)  ·  University of Aarhus (1)  ·  University of California, Davis (1)  ·  Vinmec Research Institute of Stem Cell and Gene Technology (1)

Countries

China (3)  ·  United Kingdom (2)  ·  United States (2)  ·  Denmark (1)  ·  Netherlands (1)  ·  Vietnam (1)

Top investigators

Christopher L Bowlus, MD (1)  ·  Fengchun Zhang, MD (1)  ·  Fu-Sheng Wang, professor (1)  ·  Keith D Lindor, M.D. (1)  ·  Liem Nguyen (1)  ·  M. Eric Gershwin, MD (1)  ·  Richard Burt, MD (1)  ·  Robert Chunhua Zhao, MD,PhD (1)  ·  Susanne Keiding, M.D. D.Sc. (1)  ·  Zhengsheng Zou, Dr. (1)

Results publications

PMID 27148676, PMID 28249726, PMID 40907882

NIH funding

2014 (1), 2016 (1)